Catheter Precision Inc (AMEX:VTAK) has a beta value of -0.78 and has seen 1.94 million shares traded in the last trading session. The VTAK stock price is -2796.55% off its 52-week high price of $8.40 and 17.24% above the 52-week low of $0.24.

Catheter Precision Inc (AMEX:VTAK) trade information

Sporting 2.76% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the VTAK stock price touched $0.29 or saw a rise of 6.45%. Year-to-date, Catheter Precision Inc shares have moved -34.83%, while the 5-day performance has seen it change 6.14%. Over the past 30 days, the shares of Catheter Precision Inc (AMEX:VTAK) have changed -5.19%.

Catheter Precision Inc (VTAK) estimates and forecasts

The company’s shares have lost -37.49% over the past 6 months.

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 83.47% over the past 5 years.

VTAK Dividends

Catheter Precision Inc is expected to release its next earnings report in June this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.

Also the top two Mutual Funds that are holding company’s shares are Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund . As of Mar 31, 2025 , the former fund manager holds about 0.47% shares in the company for having 43.62 shares of worth $12819.0 while later fund manager owns 10.59 shares of worth $3113.0 as of Mar 31, 2025 , which makes it owner of about 0.11% of company’s outstanding stock.